The effect of autologous conditioned serum (Orthokine) in the treatment of trigeminal neuralgia

Phase 1

Recruiting

• Conditions: Trigeminal neuralgia.; Trigeminal neuralgia; G50.0

• Registration Number: IRCT20190618043923N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Diagnosis of idiopathic trigeminal neuralgia
Complaining of severe pain refractory to oral medications

Exclusion Criteria

Bleeding disorders
Drug addiction
Drug sensitivity
Psychopathy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain duration. Timepoint: At the beginning of the study (before the intervention) and 7, 14, 21 and 28 days after the onset of the course of treatment. Method of measurement: Self-declaration.;Pain intensity. Timepoint: At the beginning of the study (before the intervention) and 7, 14, 21 and 28 days after the onset of the course of treatment. Method of measurement: Verbal rating scale ranges from 0 (no pain) to 10 (maximal pain).;Pain daily frequency. Timepoint: At the beginning of the study (before the intervention) and 7, 14, 21 and 28 days after the onset of the course of treatment. Method of measurement: Self-declaration.